Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests.

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

Premium

The company began offering testing to clinicians in the first quarter of this year and expects volume to grow significantly over the next several months.

NorthShore Moving Toward Greater Integration of Genomics Into Primary Care

Premium

After pilot programs showed patients and physicians are interested in genomics, NorthShore is working on "hardwiring" genetics into routine care.

CHOP Shares Insights, Experience From Centralized Genomic Medicine Lab

Premium

Nearly 3,500 patients were referred to the Roberts Individualized Medical Genetics Center for exome sequencing or other testing during the clinical program's first four years.

Genome BC Announces C$10M to Study Clinical Genomics Implementation

The funding, part of a larger initiative by Genome Canada, will support two studies in British Columbia that will evaluate genomics in healthcare.

Liquid Biopsy Effort Aims to Improve Diagnosis of Childhood Viral Lymphomas in Sub-Saharan Africa

Premium

A four-year, $5.5 million program will assess whether circulating cell-free DNA testing can improve diagnosis and outcomes for a type of EBV-associated cancer.

Feb 19, 2020

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

Feb 10, 2020

CDC Building NGS Quality Management Tools as Public Health Labs Increase Use of Sequencing

Premium

Feb 06, 2020

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Premium

Feb 04, 2020

SkylineDx Partners With German Hospital to Assess Multiple Myeloma Test

Jan 27, 2020

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

Jan 22, 2020

Heart Transplant Monitoring Test From TAI Diagnostics Validated in New Study

Premium

Jan 14, 2020

Illumina, Genomics England Ink Deal to Sequence up to 300K People

Jan 14, 2020

Genomic Testing Cooperative, C2i Collaborate on Liquid Biopsy Tests for Solid Tumors

Jan 13, 2020

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Jan 09, 2020

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

Premium

Jan 09, 2020

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

Jan 06, 2020

US Senators Introduce Law to Enable WGS Testing on Children With Rare Diseases

Jan 02, 2020

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Premium

Dec 20, 2019

Prostate Cancer Modeling Study Supports Precision Screening Approach

Dec 13, 2019

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

Premium

Dec 13, 2019

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

Dec 12, 2019

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Dec 11, 2019

Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

Premium

Dec 11, 2019

Menu

Genomics: Clinical Implementation

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

NorthShore Moving Toward Greater Integration of Genomics Into Primary Care

CHOP Shares Insights, Experience From Centralized Genomic Medicine Lab

Genome BC Announces C$10M to Study Clinical Genomics Implementation

Liquid Biopsy Effort Aims to Improve Diagnosis of Childhood Viral Lymphomas in Sub-Saharan Africa

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

CDC Building NGS Quality Management Tools as Public Health Labs Increase Use of Sequencing

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

SkylineDx Partners With German Hospital to Assess Multiple Myeloma Test

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

Heart Transplant Monitoring Test From TAI Diagnostics Validated in New Study

Illumina, Genomics England Ink Deal to Sequence up to 300K People

Genomic Testing Cooperative, C2i Collaborate on Liquid Biopsy Tests for Solid Tumors

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

US Senators Introduce Law to Enable WGS Testing on Children With Rare Diseases

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Prostate Cancer Modeling Study Supports Precision Screening Approach

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Sponsorships